Is Brand Name Best? Brand name versus generic pharmaceuticals in clinical practice
Bibliographic record
Abstract
In the last few years some of the biggest ‘blockbuster drugs’, that is the drugs that make pharmaceutical companies billions of dollars, have lost their patents. This means that generic manufacturers are able to produce these medications at a fraction of the cost. But what really differentiates generics from brand name medications? This commentary will explore how differences in licensing affect drug efficacy and how the pharmaceutical landscape in Canada affects patient care. RÉSUMÉ Au cours des dernières années, les brevets de certains des plus grands « médicaments vedettes», c’est-à-dire des médicaments qui rapportent des milliards de dollars aux compagnies pharmaceutiques, sont arrivés à échéance. Cela signifie que les fabricants de médicaments génériques peuvent désormais produire ceux-ci à moindre coût. Mais qu’est-ce qui différencie véritablement les mé- dicaments génériques de ceux d’origine? Ce commentaire examinera comment les différences en ce qui a trait aux licences affectent l’efficacité des médicaments, et comment le panorama pharmaceutique au Canada affecte les soins de santé.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.003 | 0.002 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.001 |
| Scholarly communication | 0.000 | 0.001 |
| Open science | 0.001 | 0.000 |
| Research integrity | 0.000 | 0.001 |
| Insufficient payload (model declined to judge) | 0.002 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".